Immunotherapy eradicates metastases with reversible defects in MHC class I expression

The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

(2010) Federico Garrido et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

(2010) Rupal Ramakrishnan et al.   JOURNAL OF CLINICAL INVESTIGATION

Finding the tumor copycat: Therapy fails, patients don't

(2010) Lee M Ellis et al.   NATURE MEDICINE

Immunotherapy of distant metastatic disease

(2009) D. Schadendorf et al.   ANNALS OF ONCOLOGY

Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy

(2009) J. Kohlmeyer et al.   CANCER RESEARCH

The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis

(2008) Eva Jiménez-Medina et al.   BMC CANCER

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

(2008) Natalia Aptsiauri et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Protein-bound polysaccharide K augments IL-2 production from murine mesenteric lymph node CD4+ T cells by modulating T cell receptor signaling

(2008) Hirobumi Asai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement

(2008) C. T. Garnett et al.   CLINICAL CANCER RESEARCH

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

(2008) Rafael Carretero et al.   IMMUNOGENETICS

Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients

(2008) Paola Nisticò et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer and Immune Response: Old and New Evidence for Future Challenges

(2008) L. de la Cruz-Merino et al.   ONCOLOGIST